They found that two well-known oncogenes (YAP1 and KRAS) direct mesenchymal cells to become undifferentiated pleomorphic ...

and myxofibrosarcoma (MFS), and has rights in the US, Canada, and Mexico. Alphamab and 3D Med, meanwhile, are running a phase 3 study in patients with advanced biliary tract cancer (BTC ...

Last year, biotech shutdowns spiked. Thankfully, 2024’s numbers are a little lower, dropping from the 27 closures in 2023 to 22 this year.

NE Bartlett et al (2021) 59 Case Report: Response to Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Recurrent Myxofibrosarcoma: A Report of 2 Cases Pembrolizumab + limb infusion of ...